Eli Lilly: Comeback Kid or Just Hype?

Eli Lilly’s stock has been in a slump, but some traders are betting it’s about to bounce back—thanks to its blockbuster weight-loss drugs. The buzz? Even with new rivals and some patients losing access, Lilly still dominates the market, and prescriptions are flying off the shelves. If you’re into playing the odds, some folks are eyeing short-term options trades for a quick win. Just remember: it’s a gamble, not a guarantee! #Business #Industry #stocks